Piramal Pharma - News

NSE: PPLPHARMA | BSE: 543635

₹209.04

₹2.45 (1.19%)

As on 29-Sep-2026 11:49IST

Market cap

₹27,792 Cr

Revenue (TTM)

₹9,205 Cr

P/E Ratio

--

P/B Ratio

3.5

Div. Yield

0 %

Quarterly Updates

2026

2025

2024

2023

2022

Annual Reports

Annual Reports

2026

Annual Reports

2025

Annual Reports

2024

Annual Reports

2023

Announcements

View Announcements

Recent

Important

Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 - ESG Rating -Niche NinetyNine Capability And Certifications (OPC) Private Limited

18-Sep-2026

Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 - FDA Inspection

14-Sep-2026

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

08-Sep-2026

Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 - ESG Rating

03-Sep-2026

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

26-Aug-2026

Sustainability Report Of Piramal Pharma Limited For The Financial Year 2025-26

24-Aug-2026

Announcement under Regulation 30 (LODR)-Acquisition

18-Aug-2026

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

18-Aug-2026

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

10-Aug-2026

Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -Resumption Of Operations At Company'S Facilities Located At Ahmedabad Gujarat

03-Aug-2026